Literature DB >> 10335712

Carbon dioxide laser debulking for obstructing endolaryngeal carcinoma: a 10-year experience.

O Laccourreye1, G Lawson, L Muscatello, B Biacabe, L Laccourreye, D Brasnu.   

Abstract

The results of the carbon dioxide (CO2) laser debulking procedure for obstructing endolaryngeal carcinoma were analyzed in terms of efficiency, complications, secondary tracheotomy rate, and peristomal recurrence rate in a series of 50 patients consecutively managed at our department. The CO2 laser was used to reestablish a safe airway without resorting to tracheotomy and without performing a transoral resection. Our series included 42 patients in a pre-definitive treatment group (group 1) and 8 patients in a palliation group (group 2). Complications included death, pneumonia from inhalation, and cutaneous burns in 2 patients, 1 patient, and 1 patient, respectively. Thirty-two percent of patients required a repeat laser treatment to maintain the airway. Overall success rates of 92.8% and 87.5% were achieved in group 1 and group 2 patients, respectively. None of the variables under analysis could predict the success of the CO2 laser debulking procedure. The overall incidences for secondary tracheotomy were 4.7% and 0% in group 1 and group 2 patients, respectively. Peristomal recurrence was not encountered in patients managed with definitive therapy with curative intent.

Entities:  

Mesh:

Year:  1999        PMID: 10335712     DOI: 10.1177/000348949910800513

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  2 in total

1.  Endoscopic airway management of acute upper airway obstruction.

Authors:  N Choudhury; V Perkins; I Amer; R Bhagrath; K Ghufoor
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-09       Impact factor: 2.503

2.  Debulking obstructing laryngeal cancers to avoid tracheotomy.

Authors:  Fatih Gul; Yagmur Canan Teleke; Gokhan Yalciner; Mehmet Ali Babademez
Journal:  Braz J Otorhinolaryngol       Date:  2019-08-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.